The Spectrum of Ocular Alterations in Patients with β-Thalassemia Syndromes Suggests a Pathology Similar to Pseudoxanthoma Elasticum

Published:December 04, 2013DOI:https://doi.org/10.1016/j.ophtha.2013.10.016

      Purpose

      To determine the prevalence and spectrum of ocular fundus abnormalities in patients with β-thalassemia and to investigate risk factors for their development.

      Design

      Cross-sectional, observational study.

      Participants

      A total of 255 patients with β-thalassemia major (TM) and β-thalassemia intermedia (TI) were consecutively recruited and investigated.

      Methods

      Patients underwent best correct visual acuity, indirect ophthalmoscopy, and fundus photography, including fundus autofluorescence (FAF) and near-infrared reflectance imaging using a confocal scanning laser ophthalmoscope (cSLO). Hematologic parameters were determined, including mean ferritin levels, aspartate amino transferase, alanine amino transferase, calcium, pre-transfusion hemoglobin, history of splenectomy, and liver iron concentration. Factors associated with the ocular phenotype were assessed using logistic regression.

      Main Outcome Measures

      Ocular phenotype as determined by clinical examination and used multimodal imaging.

      Results

      A total of 153 patients (60.0%) affected by TM and 102 patients (40.0%) affected by TI participated, of whom 216 (84.7%) were receiving iron-chelating therapy. Ocular fundus abnormalities characteristic of pseudoxanthoma elasticum (PXE) were detected by cSLO in 70 of 255 patients (27.8%) and included peau d'orange (19.6%), angioid streaks (12.9%), pattern dystrophy-like changes (7.5%), and optic disc drusen (2.0%). Pseudoxanthoma elasticum–like changes were more frequent in patients with TI ( P < 0.001). Patients with PXE-like fundus changes were older than patients without these fundus changes ( P < 0.001). In both patients with TI and TM, age ( P = 0.001) and splenectomy ( P = 0.001) had the strongest association with presence of PXE-like fundus changes in multivariate analyses. A total of 43 of 255 patients (16.9%) showed increased retinal vascular tortuosity independently of the PXE-like fundus changes, which was associated with aspartate amino transferase ( P = 0.036), hemoglobin ( P = 0.008), and ferritin levels ( P = 0.005).

      Conclusions

      Pseudoxanthoma elasticum–like fundus changes are a frequent finding in patients with β-thalassemia. In TI, these changes increase with duration or severity of the disease. This particular ocular phenotype suggests an ocular pathology similar to PXE. Retinal vascular tortuosity may be an additional disease manifestation independent of the PXE-like syndrome. Patients with long-standing disease requiring iron-chelating treatment and a history of splenectomy need regular ophthalmic checkups because they are at risk of developing PXE-like fundus changes and potentially of subsequent choroidal neovascularization.
      To read this article in full you will need to make a payment
      Subscribe to Ophthalmology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Deisseroth A.
        • Nienhuis A.
        • Lawrence J.
        • et al.
        Chromosomal localization of human beta globin gene on human chromosome 11 in somatic cell hybrids.
        Proc Natl Acad Sci U S A. 1978; 75: 1456-1460
        • Cao A.
        • Galanello R.
        Beta-thalassemia.
        Genet Med. 2010; 12: 61-76
        • Aessopos A.
        • Samarkos M.
        • Voskaridou E.
        • et al.
        Arterial calcifications in beta-thalassemia.
        Angiology. 1998; 49: 137-143
        • Aessopos A.
        • Tsironi M.
        • Polonifi K.
        • et al.
        Intervertebral disc calcification in thalassemia intermedia.
        Eur J Haematol. 2008; 80: 164-167
        • Aessopos A.
        • Farmakis D.
        • Karagiorga M.
        • et al.
        Cardiac involvement in thalassemia intermedia: a multicenter study.
        Blood. 2001; 97: 3411-3416
        • Hamlin N.
        • Beck K.
        • Bacchelli B.
        • et al.
        Acquired Pseudoxanthoma elasticum-like syndrome in beta-thalassaemia patients.
        Br J Haematol. 2003; 122: 852-854
        • Bergen A.A.
        • Plomp A.S.
        • Schuurman E.J.
        • et al.
        Mutations in ABCC6 cause pseudoxanthoma elasticum.
        Nat Genet. 2000; 25: 228-231
        • Le Saux O.
        • Martin L.
        • Aherrahrou Z.
        • et al.
        The molecular and physiological roles of ABCC6: more than meets the eye.
        Front Genet [serial online]. 2012; 3 (Available at) (Accessed September 29, 2013): 289
        • Finger R.P.
        • Charbel Issa P.
        • Ladewig M.S.
        • et al.
        Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches.
        Surv Ophthalmol. 2009; 54: 272-285
        • Charbel Issa P.
        • Finger R.P.
        • Holz F.G.
        • Scholl H.P.
        Multimodal imaging including spectral domain OCT and confocal near infrared reflectance for characterization of outer retinal pathology in pseudoxanthoma elasticum.
        Invest Ophthalmol Vis Sci. 2009; 50: 5913-5918
        • Charbel Issa P.
        • Finger R.P.
        • Gotting C.
        • et al.
        Centrifugal fundus abnormalities in pseudoxanthoma elasticum.
        Ophthalmology. 2010; 117: 1406-1414
        • Finger R.P.
        • Charbel Issa P.
        • Ladewig M.
        • et al.
        Fundus autofluorescence in Pseudoxanthoma elasticum.
        Retina. 2009; 29: 1496-1505
        • Aessopos A.
        • Stamatelos G.
        • Savvides P.
        • et al.
        Angioid streaks in homozygous beta thalassemia.
        Am J Ophthalmol. 1989; 108: 356-359
        • Gartaganis S.
        • Ismiridis K.
        • Papageorgiou O.
        • et al.
        Ocular abnormalities in patients with beta thalassemia.
        Am J Ophthalmol. 1989; 108: 699-703
        • Taher A.
        • Bashshur Z.
        • Shamseddeen W.A.
        • et al.
        Ocular findings among thalassemia patients.
        Am J Ophthalmol. 2006; 142: 704-705
        • Sorcinelli R.
        • Sitzia A.
        • Figus A.
        • Lai M.E.
        Ocular findings in beta-thalassemia.
        Metab Pediatr Syst Ophthalmol. 1990; 13: 23-25
        • Taneja R.
        • Malik P.
        • Sharma M.
        • Agarwal M.C.
        Multiple transfused thalassemia major: ocular manifestations in a hospital-based population.
        Indian J Ophthalmol. 2010; 58: 125-130
        • Incorvaia C.
        • Parmeggiani F.
        • Costagliola C.
        • et al.
        Quantitative evaluation of the retinal venous tortuosity in chronic anaemic patients affected by beta-thalassaemia major.
        Eye (Lond). 2003; 17: 324-329
        • Gliem M.
        • Zaeytijd J.D.
        • Finger R.P.
        • et al.
        An update on the ocular phenotype in patients with pseudoxanthoma elasticum.
        Front Genet [serial online]. 2013; 4 (Available at) (Accessed September 29, 2013): 14
        • Aesopos A.
        • Stamatelos G.
        • Savvides P.
        • et al.
        Pseudoxanthoma elasticum and angioid streaks in two cases of beta-thalassaemia.
        Clin Rheumatol. 1989; 8: 522-527
        • Aessopos A.
        • Savvides P.
        • Stamatelos G.
        • et al.
        Pseudoxanthoma elasticum-like skin lesions and angioid streaks in beta-thalassemia.
        Am J Hematol. 1992; 41: 159-164
        • Baccarani-Contri M.
        • Bacchelli B.
        • Boraldi F.
        • et al.
        Characterization of pseudoxanthoma elasticum-like lesions in the skin of patients with beta-thalassemia.
        J Am Acad Dermatol. 2001; 44: 33-39
        • Aessopos A.
        • Farmakis D.
        • Loukopoulos D.
        Elastic tissue abnormalities resembling pseudoxanthoma elasticum in beta thalassemia and the sickling syndromes.
        Blood. 2002; 99: 30-35
        • Martin L.
        • Douet V.
        • VanWart C.M.
        • et al.
        A mouse model of beta-thalassemia shows a liver-specific down-regulation of ABCC6 expression.
        Am J Pathol. 2011; 178: 774-783
        • Hu X.
        • Plomp A.S.
        • van Soest S.
        • et al.
        Pseudoxanthoma elasticum: a clinical, histopathological, and molecular update.
        Surv Ophthalmol. 2003; 48: 424-438
        • Jensen O.A.
        Bruch's membrane in pseudoxanthoma elasticum. Histochemical, ultrastructural, and x-ray microanalytical study of the membrane and angioid streak areas.
        Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1977; 203: 311-320
        • Friedman A.H.
        • Beckerman B.
        • Gold D.H.
        • et al.
        Drusen of the optic disc.
        Surv Ophthalmol. 1977; 21: 373-390
        • Agarwal A.
        • Patel P.
        • Adkins T.
        • Gass J.D.
        Spectrum of pattern dystrophy in pseudoxanthoma elasticum.
        Arch Ophthalmol. 2005; 123: 923-928
        • Haimovici R.
        • D'Amico D.J.
        • Gragoudas E.S.
        • et al.
        The expanded clinical spectrum of deferoxamine retinopathy.
        Ophthalmology. 2002; 109: 164-171
        • Genead M.A.
        • Fishman G.A.
        • Anastasakis A.
        • Lindeman M.
        Macular vitelliform lesion in desferrioxamine-related retinopathy.
        Doc Ophthalmol. 2010; 121: 161-166
        • Viola F.
        • Barteselli G.
        • Dell'arti L.
        • et al.
        Abnormal fundus autofluorescence results of patients in long-term treatment with deferoxamine.
        Ophthalmology. 2012; 119: 1693-1700
        • Angelucci E.
        • Brittenham G.M.
        • McLaren C.E.
        • et al.
        Hepatic iron concentration and total body iron stores in thalassemia major.
        N Engl J Med. 2000; 343: 327-331
        • Musallam K.M.
        • Cappellini M.D.
        • Taher A.T.
        Iron overload in beta-thalassemia intermedia: an emerging concern.
        Curr Opin Hematol. 2013; 20: 187-192
        • Musallam K.M.
        • Cappellini M.D.
        • Wood J.C.
        • Taher A.T.
        Iron overload in non-transfusion-dependent thalassemia: a clinical perspective.
        Blood Rev. 2012; 26: S16-S19
        • Taher A.T.
        • Musallam K.M.
        • Karimi M.
        • et al.
        Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study.
        Blood. 2010; 115: 1886-1892
        • Cappellini M.D.
        • Robbiolo L.
        • Bottasso B.M.
        • et al.
        Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia.
        Br J Haematol. 2000; 111: 467-473
        • Atichartakarn V.
        • Angchaisuksiri P.
        • Aryurachai K.
        • et al.
        Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/beta-thalassaemic patients.
        Br J Haematol. 2002; 118: 893-898
        • Tavazzi D.
        • Duca L.
        • Graziadei G.
        • et al.
        Membrane-bound iron contributes to oxidative damage of beta-thalassaemia intermedia erythrocytes.
        Br J Haematol. 2001; 112: 48-50
        • Georgalas I.
        • Papaconstantinou D.
        • Koutsandrea C.
        • et al.
        Angioid streaks, clinical course, complications, and current therapeutic management.
        Ther Clin Risk Manag. 2009; 5: 81-89
        • Jampol L.M.
        • Acheson R.
        • Eagle Jr., R.C.
        • et al.
        Calcification of Bruch's membrane in angioid streaks with homozygous sickle cell disease.
        Arch Ophthalmol. 1987; 105: 93-98
        • Aisen M.L.
        • Bacon B.R.
        • Goodman A.M.
        • Chester E.M.
        Retinal abnormalities associated with anemia.
        Arch Ophthalmol. 1983; 101: 1049-1052
        • Gass J.D.
        “Comet” lesion: an ocular sign of pseudoxanthoma elasticum.
        Retina. 2003; 23: 729-730